InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,214.08
(
0.51%
)
US TECH 100
17,724.00
(
0.47%
)
Dow Jones
39,387.76
(
0.85%
)
Brent Oil
84.09
(
0.16%
)
Bitcoin
62,956.64
(
-0.15%
)
Post# of 251777
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ghmm

Send PM Follow Ignore
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

ghmm

Re: genisi post# 181553

Saturday, 08/30/2014 8:52:11 AM

Saturday, August 30, 2014 8:52:11 AM

Post# of 251777
UTHR:

A good win for the company. Three more years to try and get patients on other formulations and/or development something else. I've been out for a while I don't have high confidence that they'll be as successful at developing/licensing other products. If the oral product were better tolerated I would have had more confidence in getting a prostacylin to work in other indications. PAH has also become quite competitive.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up